Foundation Medicine Story

Foundation Medicine -- USA Stock  

USD 73.55  0.70  0.96%

Macroaxis does not monitor all media channels or aggregates social signals for Foundation Medicine. But even though we do not provide professional-grade financial sentiment analysis on Foundation Medicine, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Foundation Medicine. Additionally see Foundation Medicine Hype Analysis, Foundation Medicine Correlation and Foundation Medicine Performance.
Exercise or conversion by Jason Ryan of 18688 shares of Foundation Medicine subject to Rule 16b-3
Filed transaction by Foundation Medicine Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Foundation Medicine Inc insider trading alert for exercise of stock option (right to buy) by Jason Ryan, Chief Financial Officer, on December 7, 2017. This event was filed by Foundation Medicine Inc with SEC on 2017-12-07. Statement of changes in beneficial ownership - SEC Form 4

Cash Floor Correlation

Click cells to compare fundamentals   View All Correlations

Story Momentum

This article from MacroaxisInsider published on 07 of December contributed to the next trading period price escalation.The overall trading delta to the next next day price was 7.79% . The overall trading delta when the story was published to current price is 17.59% .

Similar stores for Foundation Medicine

Analysts See -1.13 EPS for Foundation Medicine, Inc.news
Frisco FastballIs It Time To Sell Stock Foundation Medicine, Inc. MostVolatileStocks Foundation Medicine Inc Shorts Rose By 23.71 percent As Of Apr 22, 2018 DJZ PlanetFull coverage
over a month ago at http://www.equities.com 
Foundation Medicine Inc. Moves Higher on Volume Spike for March 09
Equities News
Equities.comWill Foundation Medicine, Inc. Run Out of Steam Soon Frisco FastballFoundation Medicine, Inc. Cant Burn Your Long Portfolio. Just Reaches All Time High KL DailyFull coverage
over two months ago at http://bzweekly.com 
It is Time to Neutral Foundation Medicine , Goldman Sachs Says ...
news
In an analyst report released today, Goldman Sachs analysts began Foundation Medicine coverage with Neutral rating, and a 73 PT. California State Teachers Retirement System Has 938000 Position in Foundation ... - The Ledger Gazette Foundation Medicine Is Now Covered By Goldman Sachs. What can We ... - KL Daily
over three months ago at http://www.truebluetribune.com 
Foundation Medicine Stock Rating Upgraded by Zacks Investment Research
news
TrueBlueTribuneEvan Fa Jones Sells 1400 Shares of Foundation Medicine Inc Stock Dispatch TribunalInsider Selling Foundation Medicine Inc CFO Sells 21726 Shares of Stock Week HeraldFull coverage

Did you try this?

Run Cryptocurrency Arbitrage Now
   

Cryptocurrency Arbitrage

Find pairs of digital assets on multiple exchanges that are traded at a risk free arbitrage
View All  Next Launch Cryptocurrency Arbitrage

Revenue

Revenue Comparative Analysis
  Revenue 
      Foundation Medicine Comparables 
Foundation Medicine is currently under evaluation in revenue category among related companies. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of business and is important item when evaluating financial statements of a company. Revenues from a firm's main business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which given company operates.

Peers

Foundation Medicine Related Equities
EXAM  Huge %   
0%
100.0%
MD  0.57 %   
0%
1.0%
FLGT  0.50 %   
0%
1.0%
VCYT  0.32 %   
0%
1.0%
AIQ  0.00 %   
0%
0%
LH  0.32 %   
1.0%
0%
ENSG  0.39 %   
1.0%
0%
EVHC  0.75 %   
1.0%
0%
DVCR  1.43 %   
1.0%
0%
AAC  1.99 %   
1.0%
0%
Additionally see Foundation Medicine Hype Analysis, Foundation Medicine Correlation and Foundation Medicine Performance. Please also try Cryptocurrency Correlation module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins and exchanges.